年表作成・共有サービス - pastport

VANCOUVER, BC, Feb. 27, 2023 /PRNewswire/ -- The Peptide Synthesis Market size was valued at USD 506.2 Million in 2021 and is expected to register a CAGR of 7.2% during the forecast period, according to a report by Emergen Research. The market growth is primarily driven by the increasing demand for peptide therapeutics for the treatment of various diseases such as cancer, metabolic disorders, and infectious diseases. The use of peptides as diagnostic tools in various fields such as oncology, neurology, and cardiology is also driving the growth of the market.

Drivers:

The increasing incidence of chronic diseases such as cancer and diabetes is driving the demand for peptide therapeutics. According to the World Health Organization, cancer is one of the leading causes of death worldwide, accounting for approximately 9.6 million deaths in 2018. Peptide therapeutics have shown promising results in the treatment of cancer and are becoming an important part of the treatment regimen. The increasing demand for personalized medicine is also driving the growth of the market.

In addition, the development of new technologies for peptide synthesis is expected to drive the market growth during the forecast period. The use of microwave-assisted solid-phase peptide synthesis and flow chemistry has significantly improved the efficiency of peptide synthesis. The use of these technologies has led to a reduction in the time and cost involved in peptide synthesis, thereby driving the growth of the market.